<?xml version="1.0" encoding="UTF-8"?>
<p>All procedures described herein were performed in compliance with the scientific and ethics committees of the Hospital Angeles Pedregal, the Declaration of Helsinki, and approved by the Comisión Federal para la Protección de Riesgos Sanitarios (COFEPRIS, CMN2012-027). Fetal tissue was obtained in 1998 at Good Samaritan Hospital (Los Angeles, CA) with institutional approval #97-11-01, within their neuro-transplantation program. Human fetal brain tissue donor informed consent forms were obtained in accordance with NIH guidelines for use of fetal tissue (available from: 
 <ext-link ext-link-type="uri" xlink:href="http://stemcells.nih.gov/staticresources/news/newsArchives/fr25au00-136.htm" xmlns:xlink="http://www.w3.org/1999/xlink">http://stemcells.nih.gov/staticresources/news/newsArchives/fr25au00-136.htm</ext-link>), as well as US federal, and CA state laws. PD patients selected for the study signed letters of informed consent of their own free will, after the protocol had been carefully described to them, emphasizing the use of human fetal tissue, and the requirement for their commitment to lengthy pre- and post-surgery evaluations. Tissue donors and NPC recipients remained unknown to each other.
</p>
